Cat.#: ASSD-140
| Description | A2B covalent ligand selectively targets lysine residue(s) on the receptor and binds persistently in radioligand displacement and wash-out assays, allowing for novel ways to interrogate the A2BAR. Apparent pKi values at A2BARs are 8.10 and 9.17 (after 4h), where a Ki shift indicates a covalent mode of action. Displays ~100 -fold selectivity for A2B compared to A1, A2A and A3 receptors. |
| Size | 50 μg |
| Chemical Name | 4-(2,6-dioxo-1-propyl-2,3,6,7-tetrahydro-1H-purin-8-yl)benzenesulfonyl fluoride |
| Molecule Weight | 352.3 |
| Molecular formula | C14H13FN4O4S |
| Purity | >95% |
| Solubility | Soluble in DMSO |
| Storage | Store at -20° C |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ASSD-135 | JC-1 (AC135) | 5 mg | inquiry |
| ASSD-124 | Fluorescent β2 antagonist [(S)-propranolol-green] (AC124) | 500 μg | inquiry |
| ASSD-104 | Hoechst 33258 (AC104) | 25 mg, 100 mg | inquiry |
| ASSD-145 | Oxazole Yellow Iodide 1mM solution (in 1mL DMSO) (AC145) | 1 mL | inquiry |
| ASSD-108 | Neutral Red Solution (0.33%) (AC108) | 50 mL, 100 mL | inquiry |
| ASSD-101 | Cresyl Violet Solution (1%) (AC101) | 250 mL, 500 mL, | inquiry |
| ASSD-107 | Modified Mayer's Hematoxylin (AC107) | 125 mL, 250 mL, 2×250mL | inquiry |
| ASSD-106 | Hoechst 33342 Staining Solution (10mg/ml) (AC106) | 5 mL, 10 mL | inquiry |
| ASSD-183 | 5-(4,6-Dichloro-s-triazin-2-ylamino)fluorescein hydrochloride (AC183) | 100 mg | inquiry |
| ASSD-156 | Crystal Violet (AC156) | 1g, 5g | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.